NDC 0573-0246

ANBESOL COLD SORE THERAPY

Allantion, Benzocaine, Camphor, Petrolatum

ANBESOL COLD SORE THERAPY is a Topical Ointment in the Human Otc Drug category. It is labeled and distributed by Wyeth Consumer Healthcare Llc. The primary component is Allantoin; Benzocaine; Camphor (synthetic); Petrolatum.

Product ID0573-0246_53858fc1-ab40-4e66-9cf5-2982b66097b8
NDC0573-0246
Product TypeHuman Otc Drug
Proprietary NameANBESOL COLD SORE THERAPY
Generic NameAllantion, Benzocaine, Camphor, Petrolatum
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2006-05-09
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart348
Labeler NameWyeth Consumer Healthcare LLC
Substance NameALLANTOIN; BENZOCAINE; CAMPHOR (SYNTHETIC); PETROLATUM
Active Ingredient Strength10 mg/g; mg/g; mg/g; mg/g
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0573-0246-26

1 TUBE in 1 BLISTER PACK (0573-0246-26) > 9 g in 1 TUBE
Marketing Start Date2008-09-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0573-0246-26 [00573024626]

ANBESOL COLD SORE THERAPY OINTMENT
Marketing CategoryOTC monograph not final
Application Numberpart348
Product TypeHUMAN OTC DRUG
Marketing Start Date2008-09-15

NDC 0573-0246-25 [00573024625]

ANBESOL COLD SORE THERAPY OINTMENT
Marketing CategoryOTC monograph not final
Application Numberpart348
Product TypeHUMAN OTC DRUG
Billing UnitGM
Marketing Start Date2006-05-09
Marketing End Date2010-06-21

Drug Details

Active Ingredients

IngredientStrength
ALLANTOIN10 mg/g

OpenFDA Data

SPL SET ID:25bcfa70-64f9-18d6-51b0-83282c2f84be
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1006096
  • 1052620

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.